pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

4,215 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1787Endpoints1391Fierce Biotech712BioSpace702BioPharma Dive526raps234onclive165fda recalls
therapy area
allOncology12360Rare Disease3229Immunology2872Cardiology2752Hematology2179Pulmonology2149Vaccines
  • ADA blocks Diabetes Care editorial on conference controversy, sparking fresh turmoil
    Turmoil at the American Diabetes Association (ADA) has intensified after leaders prevented editors of its flagship journal, Diabetes Care, from publishing an editorial and first-person accounts abo…
    STAT · 3mo agoNegative↗ source
  • Defense Secretary proposes annual testosterone screening for service members, sparking mixed expert reaction
    U.S. Defense Secretary Pete Hegseth announced that service members will have testosterone deficiency testing added to their annual physical exams. The plan targets war-fighters aged 30 and older, w…
    STAT · 3mo agoNeutral↗ source
← prev
page 114 of 169
next →
113
fda medwatch111
globenewswire health73
fda press59
1802
Psychiatry & CNS1204
Ophthalmology1062
Pain778
Endocrinology & Metabolism777
Nephrology762
Kelun-Biotech reports first-line success of Merck-partnered ADC sacituzumab tirumotecan in China
Kelun-Biotech announced that its antibody‑drug conjugate sacituzumab tirumotecan, developed in partnership with Merck, achieved its primary efficacy endpoints when used as a first‑line therapy in a…
Endpoints · 3mo agoPositive readoutNeutral↗ source
  • Arrow International issues correction for convenience kits containing recalled saline, lidocaine and bupivacaine
    Arrow International, a Teleflex subsidiary, sent a correction notice to customers about certain convenience kits. The kits contain 10 mL saline ampules, lidocaine and bupivacaine. The FDA classifi…
    fda medwatch · 3mo agoCRLNeutral↗ source
  • Uganda remains silent on Marburg outbreak updates, WHO says
    The World Health Organization noted that Uganda has not provided any new information since it announced a Marburg virus outbreak late last month. WHO officials have sent multiple requests for deta…
    STAT · 3mo agoNeutral↗ source
  • Reporter attends AHA Leadership Summit in Denver to gauge hospital executives' priorities
    The author attended the American Hospital Association’s Leadership Summit in downtown Denver earlier this week. While there, the author handed out ice cream recommendations to attendees. The prim…
    Endpoints · 3mo agoNeutral↗ source
  • Merck-Kelun ADC sac-TMT shows progression-free survival benefit with Keytruda in late-stage NSCLC trial
    Kelun-Biotech announced that its antibody‑drug conjugate sac‑TMT, developed with Merck, achieved positive Phase 3 results when paired with Keytruda in a non‑small cell lung cancer trial. The data…
    BioSpace · 3mo agoPositive readoutPositive↗ source
  • Celcuity’s breast cancer therapy gets FDA approval as new CBER chief outlines biotech priorities
    Celcuity announced that its first breast cancer drug has been approved by the U.S. Food and Drug Administration, marking the company’s initial market entry in oncology. The announcement coincided…
    STAT · 3mo agoApprovalPositive↗ source
  • J&J restructures pharma supply chain, offloading sites as part of $55 B U.S. manufacturing push
    Johnson & Johnson announced it is restructuring its pharmaceutical supply chain, offloading certain sites to streamline operations as part of its $55 billion U.S. manufacturing initiative. The cha…
    BioSpace · 3mo agoPositive↗ source
  • Medicare proposes ban on vendor-provided remote patient monitoring services
    Medicare regulators have proposed a rule that would prohibit vendors from delivering remote patient monitoring services on behalf of physicians, marking a significant policy shift. Remote patient…
    STAT · 3mo agoRegulatoryNegative↗ source
  • Senator Lindsey Graham’s death highlights gaps in detecting aortic dissection
    Senator Lindsey Graham, 71, died on Saturday after suffering an aortic dissection, a sudden tear in the body's main blood vessel that can be fatal. A final death certificate has not yet been relea…
    STAT · 3mo agoNegative↗ source
  • Senate hearing probes CDC nominee Erica Schwartz amid concerns over political pressure from RFK Jr. and Trump
    Senate leaders questioned Erica Schwartz, the administration's nominee to head the CDC, about her ability to resist political pressure during a Wednesday hearing. Lawmakers referenced the earlier…
    STAT · 3mo agoRegulatoryNeutral↗ source
  • FDA acting chief says two journal articles by former commissioner do not represent agency policy
    Acting FDA Commissioner Kyle Diamantas announced that the agency is reversing its earlier position regarding two medical‑journal articles authored by former commissioner Marty Makary. The FDA now…
    Endpoints · 3mo agoRegulatoryNeutral↗ source
  • New blood-based Alzheimer’s tests promise easier, more detailed diagnosis
    At the recent Alzheimer’s Association International Conference, researchers presented advances that could make Alzheimer’s testing more widely available and informative. Current diagnostic methods…
    STAT · 3mo agoPositive↗ source
  • Senator Cassidy challenges Trump pandemic nominee over anti-vaccine LinkedIn post
    Senate Health Committee Chairman Bill Cassidy confronted Sean Kaufman, President Trump's nominee for a senior pandemic preparedness position, during the confirmation hearing. Cassidy cited a delet…
    STAT · 3mo agoRegulatoryNegative↗ source
  • Johnson & Johnson to spend up to $750 million restructuring pharma manufacturing and closing plants
    Johnson & Johnson announced it will incur up to $750 million as it reshapes its pharmaceutical manufacturing network. The plan involves exiting certain factories and consolidating production, aimi…
    Endpoints · 3mo agoNeutral↗ source
  • Glenmark agrees to $29.6 million settlement over generic drug price-fixing claims
    Glenmark Pharmaceuticals has reached a settlement with dozens of U.S. states, agreeing to pay $29.6 million to resolve accusations that it participated in a scheme to inflate prices of generic medi…
    STAT · 3mo agoDealNegative↗ source
  • AdvanCell secures $315M Series D to advance lead-based prostate cancer therapy
    AdvanCell announced a $315 million Series D financing round aimed at supporting development of its lead-based prostate cancer agent and expanding U.S. manufacturing capacity for the radioactive tre…
    Endpoints · 3mo agoDealPositive↗ source
  • J&J reports 18,000 new prescriptions for Icotyde in first full quarter
    Johnson & Johnson gave an update on the launch of its plaque-psoriasis drug Icotyde. The company said that in its first full quarter on the market, Icotyde generated about 18,000 new prescriptions…
    Endpoints · 3mo agoPositive readoutPositive↗ source
  • Ebola outbreak in Congo tops 2,000 cases as health workers strike over unpaid wages
    The Congo Ministry of Health reported on July 15 that confirmed Ebola cases have risen to 2,011, with 754 deaths, making it the fastest-growing outbreak on record. Health workers at Bunia General…
    STAT · 3mo agoNegative↗ source
  • Biogen’s experimental Alzheimer’s therapy shows comparable slowing of cognitive decline in mid-stage trial, paving way to Phase 3
    Biogen reported that its experimental Alzheimer’s drug slowed cognitive decline in a mid-stage study. The trial showed patients experienced a rate of decline similar to that seen with currently app…
    STAT · 3mo agoPositive readoutPositive↗ source
  • Nava Therapeutics raises $89 million to advance lipid nanoparticle platform targeting bone marrow, immune cells and kidney
    Nava Therapeutics, a stealth-mode biotech, announced it has secured $89 million in financing, according to a statement to Endpoints News. The capital will support development of a next generation…
    Endpoints · 3mo agoDealPositive↗ source
  • Braveheart Bio seeks Nasdaq listing to finance Phase 3 trial of Hengrui rival cardio drug
    Braveheart Bio announced it has filed for an initial public offering on the Nasdaq exchange. The company says the capital raised will be used to fund a Phase 3 study of its cardiovascular candidate…
    Endpoints · 3mo agoNeutral↗ source
  • Insilico Medicine and Bora Pharma launch AI-driven biologics manufacturing venture to challenge Chinese CDMOs
    Insilico Medicine, an AI drug discovery company, and Bora Pharmaceuticals, a Taiwan-based CDMO, announced the formation of a new joint venture. The new company will develop an AI-driven platform t…
    Endpoints · 3mo agoDealPositive↗ source
  • Bipartisan lawmakers demand AI use details from top Medicare Advantage insurers amid care denial concerns
    Senators Richard Blumenthal and Josh Hawley have written to UnitedHealth, Humana, CVS and other large Medicare Advantage insurers asking for internal records that detail how artificial intelligence…
    STAT · 3mo agoRegulatoryNegative↗ source